Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer(legacy) | 204 |
| SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer(legacy) | 68 |
Total Visits per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer | 0 | 0 | 0 | 3 | 2 | 18 | 0 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 70 |
| China | 14 |
| Australia | 10 |
| Hong Kong SAR China | 10 |
| Netherlands | 8 |
| Vietnam | 8 |
| France | 6 |
| Sweden | 2 |
| Singapore | 2 |
Top City Views
| Views | |
|---|---|
| Ashburn | 29 |
| Fairfield | 13 |
| Beijing | 10 |
| Kaleen | 9 |
| Hanoi | 8 |
| Rotterdam | 8 |
| Cambridge | 5 |
| Hanover | 4 |
| New York | 2 |
| San Francisco | 2 |